StockData
Ocular Therapeutix, Inc logo

Ocular Therapeutix, Inc (OCUL) stock

OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3011% above fair value
$6.02+0.01 (+0.17%)

Close on Nov 17, 2026Market cap $1.32BP/E –Yield –

Ocular Therapeutix price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ocular Therapeutix's price to book ratio was 2.8× on Nov 11, 2026, against 8.2× a year earlier. Over the last 5 years it ranged from 2.2× to 97.0×, with a median of 4.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.8×−5.4
2025Dec 31, 20258.2×+4.4
2024Dec 31, 20243.8×−41.3
2023Dec 29, 202345.1×+40.4
2022Dec 30, 20224.7×−1.4
2021Dec 31, 20216.1×−105.8
2020Oct 30, 2020111.9×+95.1
2019Dec 31, 201916.8×+13.3
2018Dec 31, 20183.5×−0.1
2017Dec 29, 20173.6×+0.3
2016Dec 30, 20163.3×+1.0
2015Dec 31, 20152.3×−5.3
2014Dec 31, 20147.6×–

More Ocular Therapeutix figures

See a number that looks wrong?